Treatment of Attention Deficit-Hyperactivity Disorder in a Pediatric Patient with COVID-19

Authors : Asiye ARICI GÜRBÜZ, Hatice ALTUN

Pages : 141-144

Doi:10.17517/ksutfd.1100749

View : 47 | Download : 96

Publication Date : 2023-07-12

Article Type : Other Papers

Abstract :It is unknown that the novel Coronavirus insert ignore into journalissuearticles values(COVID-19);, which emerged for the first time in December 2019 and spread all over the world, have affected how many children symptomatically or asymptomatically. The uncertainty of the treatment algorithm of pandemic factor and rapidly developing pandemic process created a chaotic environment in whole world. Children and adolescents have been adversely affected by this chaotic environment. Studies examining the effects of this period on the mental health of children and adolescents are scarce. It has been suggested that individuals with psychiatric disorders such as attention deficit-hyperactivity disorder insert ignore into journalissuearticles values(ADHD); and autism spectrum disorder insert ignore into journalissuearticles values(ASD); adapted more difficultly and were affected more negatively than other individuals. In this study, we present a patient with ADHD and oppositional defiant disorder insert ignore into journalissuearticles values(ODD); who was using short-acting methylphenidate insert ignore into journalissuearticles values(IRISMPH); for treatment, had no worsening or any adverse side effects and was treated carefully for COVID-19 infection. However, further studies are required to evaluate the safety of IRIS-MPH and other psychotropic agents in patients with COVID-19.
Keywords : Kovid 19, dikkat eksikliği hiperaktivite bozukluğu, metilfenidat, risperidon, tedavi, çocuk